In these patients, the growth and survival of tumor cells have become exclusively dependent on the aberrant activation of EGFR, termed an ‘oncogene-addicted’ state [5], and therefore, activated EGFR is an ideal therapeutic target. The gene discussed is EGFR; the disease is neoplasm.